Prediction of drug sensitivity in individuals with atypical serum cholinesterase based on in vitro biochemical studies.
D000085:Acetates; D001241:Aspirin; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D002802:Cholinesterases / Q000097:blood*; D004361:Drug Tolerance; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D009284:Naphthols; D010654:Phenylbutyrates; D011343:Procaine; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D013379:Substrate Specificity; D013390:Succinylcholine / Q000009:adverse effects; D013748:Tetracaine
D000085:Acetates; D002800:Cholinesterase Inhibitors; D009284:Naphthols; D010654:Phenylbutyrates; D000644:Quaternary Ammonium Compounds; D013748:Tetracaine; C016013:2-nitrophenyl butyrate; C005366:naphthyl acetate; D011343:Procaine; D002802:Cholinesterases; C027917:tetramethylammonium; D013390:Succinylcholine; D001241:Aspirin